{
    "2019-08-22": [
        [
            {
                "time": "2023-10-01",
                "original_text": "药明康德(02359.HK)认购200万美元基金份额重点投资生命科学",
                "features": {
                    "keywords": [
                        "药明康德",
                        "认购",
                        "基金",
                        "生命科学"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生命科学"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "茅台再创新高，大消费是否真的独孤求败？",
                "features": {
                    "keywords": [
                        "茅台",
                        "创新高",
                        "大消费"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "消费品"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "药明康德投资版图受损：归母净利跌16.91% 最大毛利来源扭头下滑 盈利能力下降",
                "features": {
                    "keywords": [
                        "药明康德",
                        "归母净利",
                        "盈利能力",
                        "下滑"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "摩通：药明康德(2359.HK)增长强劲 升目标价至95港元",
                "features": {
                    "keywords": [
                        "摩通",
                        "药明康德",
                        "增长强劲",
                        "目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}